Boehringer Ingelheim quadruples the number of its tenders via the Transporeon platform

Boehringer Ingelheim was the first pharmaceutical company to fully outsource its operative tender management process to Transporeon in 2020. One year later, the benefits of this step have become clearly visible.

In the current volatile market situation characterized by fluctuating prices, Boehringer Ingelheim was able to quadruple its logistics tenders (one per quarter instead of one per year) and ensure the robustness of its logistics processes. At the same time, Boehringer Ingelheim retains full control of all strategic decisions: the schedule, the scope of the tender, and the pool of service providers are managed by the pharmaceutical company itself.

By working with Transporeon, Boehringer Ingelheim receives better service at a lower cost. Even in times of reduced transport capacity, the pharmaceutical company obtains attractive offers via Transporeon’s active tender management. In parallel, costs and effort for the internal coordination of the tendering process decrease.

In addition, the logistics experts from Ulm regularly supply market insights to Boehringer Ingelheim to facilitate navigating the current volatile market situation, as part of their procurement excellence programme. These analyses by Transporeon have proven essential for making long-term strategic decisions.

Sören Brodowy, Head of Global Sourcing Logistics at Boehringer Ingelheim, said: “Working closely with the Transporeon employees is of paramount importance for us. They are the logistics experts for the execution of the tendering process, as well as data processing, validation and analyses”.

Expanding this partnership in the future is highly likely. Boehringer Ingelheim successfully introduced Transporeon’s spot tendering tool at a site in Belgium to bridge the shortage of air freight capacity during the pandemic. Due to this success, the pharmaceutical company is considering deploying the spot tool developed for air and ship freight across the entire company in the medium-term.

Boehringer Ingelheim and Transporeon have been working together as trusted partners in the field of contract tendering since 2010.

 

Leave a Reply

Your email address will not be published. Required fields are marked *